Drug & medication recalls Moderate risk

Pfizer Inc. recalls Zoloft (sertraline HCl) tablets 25 mg* 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., NY, NY,…

Recall date
October 20, 2017
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
D-0151-2018
FDA classification
Class II
Brand / firm
Pfizer Inc.
Sold / distributed
Nationwide in the USA

Why it was recalled

SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Zoloft (sertraline HCl) tablets 25 mg* 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., NY, NY, 10017 NDC 0049-4960-30

Get recall alerts

Free email alert whenever Pfizer Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Pfizer Inc.